Ad is loading...
MENU

SRPT Stock Tickeron detected bearish Stock Pattern: Dead Cat Bounce SRPT on September 16, 2024, netting in a 8.29% gain over 2 months

A.I.dvisor
at Tickeron.com
Loading...
+8.29% Gain from a Successful pattern Dead Cat Bounce
SRPT - Sarepta Therapeutics
Tickeron
Ticker: SRPT
Company: Sarepta Therapeutics
Gain from shortening: +8.29%
Confirmed: 09/16/24
Succeeded: 11/12/24
Total length: 60 days
On September 13, 2024, A.I.dvisor detected a Dead Cat Bounce Pattern (Bearish) for Sarepta Therapeutics (SRPT, $124.65). 3 days later, on September 16, 2024, A.I.dvisor confirmed the Bearish pattern, setting a target price of the stock. On November 12, 2024, the stock hit the target price of $112.07 – resulting in a gain for traders who shorted the stock on the pattern detection date.

SRPT sees MACD Histogram just turned negative

SRPT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 04, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 01, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on SRPT as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

SRPT moved below its 50-day moving average on November 07, 2024 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SRPT crossed bearishly below the 50-day moving average on November 08, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for SRPT moved below the 200-day moving average on October 16, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRPT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SRPT entered a downward trend on October 14, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SRPT advanced for three days, in of 303 cases, the price rose further within the following month. The odds of a continued upward trend are .

SRPT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SRPT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRPT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.177) is normal, around the industry mean (14.849). P/E Ratio (67.883) is within average values for comparable stocks, (95.928). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.788). SRPT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (6.414) is also within normal values, averaging (211.128).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SRPT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of treatments for life-threatening illnesses and viruses

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
215 First Street
Phone
+1 617 274-4000
Employees
1314
Web
https://www.sarepta.com